PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Anti-microbial resistance has emerged as a major global threat. Due to lack of rapid AST tests, generic antibiotics are typically prescribed. Pathogens possess various metabolic biomarkers such as NAD(P)H and flavins which exhibit auto fluorescence. A rapid phenotypic point-of-care AST device is developed that leverages the changes in the autofluorescence when the pathogens encounter antibiotic stress. The device is integrated with multiple wavelength sources to excite various biomarkers, and a CMOS camera integrated with optical filters to capture the emitted autofluorescence intensity. The results show that the device is capable of determining antibiotic susceptibility with its significant minimum inhibitory concentration in under 5 hours suitable for point-of-care testing.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.